Understanding 2026 Hemp Total THC Regulation and Patient Access
The 2026 hemp total THC regulation may redefine legal hemp products by including THCA and other precursors in total THC calculations. This change could affect patient access to currently legal hemp-derived cannabinoids. Clinicians should monitor these…
Cannabis Dispensary Owner Raises Alarm on 7-OH Product Safety
7-OH product safety concerns are rising as potent kratom-derived opioids enter unregulated markets. Cannabis dispensary owners urge local action to protect patients. Awareness of these risks is critical for clinical safety.
Blacksburg Prepares for Legal Cannabis Market Launch
Blacksburg cannabis market regulation is advancing as the town prepares for legal cannabis retail. Local rules focus on product safety, testing, and market access. Clinicians and patients should understand these regulations for informed cannabis use.
The ‘Silent Killer of Cannabis Greenhouse Margins’
Cannabis greenhouse margins are critical to cultivation efficiency and product consistency. Challenges in these margins can disrupt the medical cannabis supply chain. Understanding these issues helps protect patient access to quality cannabis products.
Shaw Quoted on Cannabis IP Protection Before Legalization – Vorys
Intellectual property protections cannabis are crucial for ensuring clinical access to standardized, research-validated products. As cannabis moves toward regulated medicine, IP frameworks shape product consistency and availability. This article…
Dabstract and Trulieve Collaborate on Maryland Cannabis Product Launch
Maryland medical cannabis standardization is advancing through a new partnership between Dabstract and Trulieve. This collaboration aims to enhance product quality and consistency in the Maryland market. Patients and clinicians should monitor therapeutic…
A Manufacturer’s Efficiency-First Approach to Cannabis Extraction – Powder & Bulk Solids
Cannabis extraction efficiency is critical for ensuring consistent product quality and patient access. Efficient extraction methods improve cannabinoid profiles and reduce costs. This approach supports standardized medical cannabis products for better…
US Cannabis Companies Could ‘Ring the Bell’ at US Stock Markets Under New Bill
Public market access cannabis companies would change the industry's capital structure significantly. This new bill could accelerate research and development of standardized medical cannabis products. Public market access cannabis companies may lead to…
This $100 Million Vape Company Is A Pillar Of The Cannabis Industry – YouTube
Commercial vaporizer companies play a crucial role in medical cannabis by ensuring product quality and dosing consistency. Understanding these companies helps clinicians recommend safe and effective vaporizers. This focus on commercial vaporizer…
De-Risking the Future: What’s Holding Traditional Industry Back from Cannabis Investment?
Investment patterns in cannabis directly impact research funding and product development. Traditional industry hesitancy creates a capital gap limiting clinical trials and pharmaceutical-grade products. Understanding these investment barriers is key to…